A Letter from our CEO
As we begin a new year, I want to take a moment to reflect on where VIC Technology Venture Development stands today and where we believe we are headed. The past year reinforced something we have long believed: building...
Calvin Goforth, PhD
Recent Posts
The Life Science Investor Roadmap: Navigating Funding Pathways from Seed to Exit
Investing in life sciences is both challenging and rewarding. The sector demands significant capital, long timelines, and careful diligence, but it also offers the chance to back breakthroughs that improve and save...
Adapting to the New Normal: How Early-Stage Life Science Companies and Investors Can Navigate Uncertainty
The life sciences industry has always been shaped by waves of disruption, but in 2025 the turbulence feels more structural than cyclical. Early-stage companies and their investors now find themselves facing delayed...
A Letter From Our CEO
As we reflect on the past year, I am proud to share that VIC Tech has once again demonstrated resilience and ingenuity in a challenging venture capital landscape. Despite continued headwinds, 2024 was marked by...
Should Life Science Investors Invest in the Horse or the Jockey?
When considering early-stage investment opportunities, many investors emphasize the team over the business opportunity, i.e., they bet on the jockey more than the horse. However, in the realm of life science startup...
Navigating Investment Opportunities in Medical Devices: A Guide for Savvy Investors
In the ever-evolving healthcare landscape, technological innovations continue to drive significant advancements. In this article, we delve into the realm of medical device investment, exploring key trends,...
A Letter from our CEO
In the past year, we saw great achievements across our portfolio of high-impact life science companies despite a challenging overall fundraising environment. Our VIC Tech team and the portfolio company teams showed...
The Genomic Revolution: Unveiling Personalized Medicine's Investment Potential
In healthcare, a paradigm shift is underway – one that promises to transform healthcare as we know it. The emergence of personalized medicine, fueled by groundbreaking advancements in genomics and diagnostics, can save...
FDA Breakthrough Device Designation for High Impact Medical Devices
Within the VIC Tech portfolio, SFC Fluidics and Solenic Medical have both announced FDA Breakthrough Device designation. But what is FDA Breakthrough Device designation and what benefits does it provide? From a...
The Advantages of Investing in Venture Creation Firms Like VIC Tech
In the world of early stage investing, traditional venture capital funds have long been the go-to option for investors seeking exposure to high-growth opportunity companies. However, a different investment model is...
